StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · VCRE·Healthcare

Vicore Pharma Holding AB Stock Analysis & AI Score

Vicore Pharma Holding AB (VCRE) has an ST Score of 42.1 (C), driven by its Financial Strength (A+) and held back by its Profitability (D). VCRE last traded at $9.91.

Market Closed
$9.91
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
42
ST Score
42.1/100C

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryBiotechnology
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

VCRE
42.1out of 100
Grade C

Vicore Pharma Holding AB (VCRE) has an ST Score of 42.1 (C), driven by its Financial Strength (A+) and held back by its Profitability (D). VCRE last traded at $9.91.

Strongest
Financial StrengthA+
Weakest
ProfitabilityD
All factor grades
  • Financial StrengthA+
  • ValuationC
  • GrowthC-
  • MomentumD+
  • ProfitabilityD
Score methodology
Press Releases

Contact

VCRE stock: frequently asked questions

What is VCRE's ST Score?

Vicore Pharma Holding AB (VCRE) has an ST Score of 42.1 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is VCRE a buy, hold, or sell?

Our ST Score grades it C (42.1/100). The ST Score is a data-driven signal, not a recommendation.

What are VCRE's factor grades?

Valuation C, Profitability D, Financial Strength A+, Momentum D+, Growth C-.

What is VCRE's valuation grade?

Vicore Pharma Holding AB (VCRE) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is VCRE's growth grade?

Vicore Pharma Holding AB (VCRE) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is VCRE's profitability grade?

Vicore Pharma Holding AB (VCRE) earns a profitability grade of D, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is VCRE's financial strength grade?

Vicore Pharma Holding AB (VCRE) earns a financial strength grade of A+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.